Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032908546> ?p ?o ?g. }
- W3032908546 endingPage "83.e6" @default.
- W3032908546 startingPage "72" @default.
- W3032908546 abstract "Inhibition of CYP450-mediated retinoic acid (RA) metabolism by RA metabolism blocking agents increases endogenous retinoids and is an alternative to retinoid therapy. Currently available RA metabolism blocking agents (i.e., liarozole and talarozole) tend to have fewer adverse effects than traditional retinoids but lack target specificity. Substrate-based inhibitor DX314 has enhanced selectivity for RA-metabolizing enzyme CYP26B1 and may offer an improved treatment option for keratinization disorders such as congenital ichthyosis and Darier disease. In this study, we used RT-qPCR, RNA sequencing, pathway, upstream regulator, and histological analyses to demonstrate that DX314 can potentiate the effects of all-trans-RA in healthy and diseased reconstructed human epidermis. We unexpectedly discovered that DX314, but not all-trans-RA or previous RA metabolism blocking agents, appears to protect epidermal barrier integrity. In addition, DX314-induced keratinization and epidermal proliferation effects are observed in a rhino mice model. Altogether, the results indicate that DX314 inhibits all-trans-RA metabolism with minimal off-target activity and shows therapeutic similarity to topical retinoids in vitro and in vivo. Findings of a barrier-protecting effect require further mechanistic study but may lead to a unique strategy in barrier-reinforcing therapies. DX314 is a promising candidate compound for further study and development in the context of keratinization disorders." @default.
- W3032908546 created "2020-06-12" @default.
- W3032908546 creator A5011128677 @default.
- W3032908546 creator A5020095047 @default.
- W3032908546 creator A5021793523 @default.
- W3032908546 creator A5032412768 @default.
- W3032908546 creator A5051575977 @default.
- W3032908546 creator A5058199075 @default.
- W3032908546 creator A5062785051 @default.
- W3032908546 creator A5076550626 @default.
- W3032908546 date "2021-01-01" @default.
- W3032908546 modified "2023-09-26" @default.
- W3032908546 title "Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders" @default.
- W3032908546 cites W1521867551 @default.
- W3032908546 cites W1533336527 @default.
- W3032908546 cites W1542669094 @default.
- W3032908546 cites W1551998217 @default.
- W3032908546 cites W1581075759 @default.
- W3032908546 cites W1924401591 @default.
- W3032908546 cites W1967549966 @default.
- W3032908546 cites W1975127503 @default.
- W3032908546 cites W1975172406 @default.
- W3032908546 cites W1981515453 @default.
- W3032908546 cites W1983568395 @default.
- W3032908546 cites W1987015606 @default.
- W3032908546 cites W1987128150 @default.
- W3032908546 cites W1988381039 @default.
- W3032908546 cites W1993506358 @default.
- W3032908546 cites W2001238939 @default.
- W3032908546 cites W2004755607 @default.
- W3032908546 cites W2008298934 @default.
- W3032908546 cites W2010822504 @default.
- W3032908546 cites W2015014803 @default.
- W3032908546 cites W2015363515 @default.
- W3032908546 cites W2016099444 @default.
- W3032908546 cites W2016599510 @default.
- W3032908546 cites W2018807372 @default.
- W3032908546 cites W2019736888 @default.
- W3032908546 cites W2020403959 @default.
- W3032908546 cites W2022987234 @default.
- W3032908546 cites W2025423123 @default.
- W3032908546 cites W2027030111 @default.
- W3032908546 cites W2036733405 @default.
- W3032908546 cites W2041465863 @default.
- W3032908546 cites W2044112794 @default.
- W3032908546 cites W2045949302 @default.
- W3032908546 cites W2049567155 @default.
- W3032908546 cites W2049681230 @default.
- W3032908546 cites W2049901124 @default.
- W3032908546 cites W2051663421 @default.
- W3032908546 cites W2054327488 @default.
- W3032908546 cites W2056006467 @default.
- W3032908546 cites W2056566680 @default.
- W3032908546 cites W2064115372 @default.
- W3032908546 cites W2066851739 @default.
- W3032908546 cites W2071573565 @default.
- W3032908546 cites W2074519709 @default.
- W3032908546 cites W2082079445 @default.
- W3032908546 cites W2087706552 @default.
- W3032908546 cites W2089123979 @default.
- W3032908546 cites W2089189711 @default.
- W3032908546 cites W2094029304 @default.
- W3032908546 cites W2099844663 @default.
- W3032908546 cites W2102278945 @default.
- W3032908546 cites W2104005232 @default.
- W3032908546 cites W2108060879 @default.
- W3032908546 cites W2108234281 @default.
- W3032908546 cites W2114145258 @default.
- W3032908546 cites W2120478364 @default.
- W3032908546 cites W2131271579 @default.
- W3032908546 cites W2149918429 @default.
- W3032908546 cites W2151931731 @default.
- W3032908546 cites W2158293853 @default.
- W3032908546 cites W2160790213 @default.
- W3032908546 cites W2162143298 @default.
- W3032908546 cites W2163657392 @default.
- W3032908546 cites W2167279371 @default.
- W3032908546 cites W2171990522 @default.
- W3032908546 cites W2179438025 @default.
- W3032908546 cites W2187525303 @default.
- W3032908546 cites W2287929927 @default.
- W3032908546 cites W2292837418 @default.
- W3032908546 cites W2413600578 @default.
- W3032908546 cites W2510875395 @default.
- W3032908546 cites W2740167057 @default.
- W3032908546 cites W2950221693 @default.
- W3032908546 cites W30734335 @default.
- W3032908546 cites W4232327651 @default.
- W3032908546 cites W4253127458 @default.
- W3032908546 doi "https://doi.org/10.1016/j.jid.2020.05.090" @default.
- W3032908546 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8183296" @default.
- W3032908546 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32505549" @default.
- W3032908546 hasPublicationYear "2021" @default.
- W3032908546 type Work @default.
- W3032908546 sameAs 3032908546 @default.
- W3032908546 citedByCount "8" @default.
- W3032908546 countsByYear W30329085462021 @default.
- W3032908546 countsByYear W30329085462022 @default.